Pharma Financial Squeeze Bodes Ill for Genomics
‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.
Discussion
No comments for “Pharma Financial Squeeze Bodes Ill for Genomics”
Discussion
No comments for “Pharma Financial Squeeze Bodes Ill for Genomics”
Post a comment